Palsonify (Paltusotine)

Palsonify (paltusotine) is a somatostatin receptor agonist indicated for the treatment of adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option

Recommended Dosage:
The recommended initial dosage of Paltusotine is 40 mg once daily. Take this therapeutic drug orally once daily with water on an empty stomach, at least 6 hours after a meal (e.g., after overnight fasting) and at least 1 hour before the next meal.
During the initiation period, treatment may be temporarily reduced to 20 mg once daily if required, based on tolerability. Once side effects have resolved, resume Paltusotine 40 mg once daily. After 2 to 4 weeks on Paltusotine 40 mg once daily, based on IGF-1 levels, titrate to a Paltusotine dosage of 60 mg once daily.

• Treatment with Paltusotine 20 mg/30 mg may increase the probability of gallstone formation because it reduces the movement of the gallbladder. Patients may experience nausea, abdominal pain, or inflammation of the gallbladder. Regular monitoring through ultrasound is required, mainly for those with a known history of gallbladder disease.
• This therapeutic drug can affect the levels of blood sugar by altering insulin and glucose regulation. Some patients may experience high or low blood sugar, particularly those with diabetes. Regular monitoring of blood glucose and adjustment of antidiabetic medicines are important during treatment.
• Treatment with this oral drug may cause alterations in heart rate or blood pressure in some populations. Patients with underlying heart complications must be monitored for conduction issues, slow heartbeat, or rhythm disturbances. Let your clinician know immediately if signs and symptoms like palpitations or dizziness occur.
• Because this medicinal product can affect digestive enzymes, some individuals may encounter loose motions, fatty stools, or difficulty digesting fats. This may cause abdominal discomfort or nutrient deficiencies. Dietary adjustments or supplementation may be required depending on medical instructions.
• Long-term use of this medicine may reduce Vitamin B12 absorption in some populations. This can result in numbness, fatigue, or weakness. Periodic monitoring of Vitamin B12 levels and supplementation, if needed, can prevent deficiencies during extended therapy.
• Paltusotine 20 mg/30 mg may fluctuate thyroid hormone levels. Patients may develop symptoms like weight changes, fatigue, or sensitivity to cold. Regular thyroid function tests are required, particularly for those with pre-existing thyroid complications or those showing abnormal symptoms.
• Paltusotine treatment can be used during pregnancy only if clearly required and prescribed by a healthcare provider. Its effects on unborn babies are not completely established. Women who are pregnant or want to become pregnant should discuss all the risks and benefits with their clinician.
• Paltusotine may pass into human breast milk. Therefore, breastfeeding mothers should use this therapeutic drug cautiously. Healthcare providers may recommend stopping breastfeeding or considering an alternative therapy depending on the clinical circumstances and all the risks to the infant.

What documents are required to import PALSONIFY to India?

PALSONIFY (Paltusotine) tablet can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is PALSONIFY available in India?

PALSONIFY (paltusotine tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Palsonify in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

PALSONIFY can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of PALSONIFY (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Palsonify tablet 20 mg/30 mg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source PALSONIFY (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Palsonify®?

Paltusotine is the Generic Name for the trade name drug Palsonify®.

What is the Manufacturer’s Name of Palsonify®?

Palsonify® is manufactured by Crinetics Pharmaceuticals, Inc.

Is Palsonify approved by the FDA?

Yes. Palsonify is approved by the FDA. date of first approval: September 25, 2025.

What is the dosage and form of Palsonify® supplied?

Palsonify is supplied as Tablets: 20 mg and 30 mg of Paltusotine for oral use.

What are the most common side effects of Palsonify® 20 mg/30 mg Tablets?

The most commonly reported side effects of Palsonify® are diarrhea, nausea, abdominal pain, decreased appetite, palpitations, sinus bradycardia, hyperglycemia, and gastroenteritis.

How much does Palsonify® Tablet 20 mg/30 mg cost in India?

Palsonify® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Palsonify prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Palsonify tablet 20 mg/30 mg cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can Palsonify® 20 mg/30 mg Tablets be available in SAARC countries?

Apart from Gulf countries, Palsonify® 20 mg/30 mg can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Palsonify® tablet in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Palsonify® 20 mg/30 mg Tablets online in India?

Yes, one can buy Palsonify 20 mg/30 mg tablet online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the legal supply of Palsonify® tablet through legal channels.

What are the storage conditions of Palsonify® 20 mg/30 mg Tablets?

Palsonify® 20 mg/30 mg tablets are packaged in a child-resistant container; keep out of reach of children. Store them at 20°C to 25°C (68°F to 77°F). Excursions permitted 15°C to 30°C (59°F to 86°F). Store and dispense in the original container or a USP equivalent tight container.